IteraMed News
Sports Illustrated Runs Article on “Super-CBD” with Potentional in Traumatic Head Injury
Bill Kinney and Doug Brenneman are featured in Sports Illustrated article about the potential of cannabidiol (CBD) in traumatic head injury and a new improved "Super-CBD" or KLS-13019 that is 50 times more potent, >400 times safer, 10 times more orally...
Publication at ACS Medicinal Chemistry Letters entitled, “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability”
The research behind the identification of KLS-13019 as a Lead Candidate has been published in American Chemical Society’s ACS Medicinal Chemistry Letters. This novel cannabidiol-like compound has potential to treat neurodegenerative and oxidative stress related...
Presentation at Drug Discovery Re-Invented Conference entitled: THE ARCHITECTURE AND SCIENCE OF VIRTUAL DRUG DISCOVERY IN THE CANNABINOID SPACE
Ascot, UK, Dr. Kinney will describe for the first time a new family of molecules with improvements over Cannabidiol (“CBD”), a non-psychoactive neuroprotective agent from C. sativa. IteraMed Consulting has functioned as Kannalife Sciences' medicinal and scientific...
KannaLife Sciences, Inc. Signs Research and Development Agreements With Advanced Neural Dynamics and IteraMed in the Discovery of Novel Neuroprotectants
KannaLife Sciences, Inc. (“KannaLife”) announces its collaboration with two experienced drug discovery organizations: Advanced Neural Dynamics and IteraMed. KannaLife will fund a new drug discovery project related to a laboratory validated phytochemical. The founding...